4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465826-13-000003
Chief Scientific Officer sold 1,974,140 shares at an average $0.12 ($230,818)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NIGALAYE ASHOK G Chief Scientific Officer | 2013-11-14 | Sale | −465,090 | $0.12 | $53,578 | 24,200,069 | I |
| NIGALAYE ASHOK G Chief Scientific Officer | 2013-11-15 | Sale | −318,050 | $0.12 | $37,307 | 24,095,113 | I |
| NIGALAYE ASHOK G Chief Scientific Officer | 2013-11-18 | Sale | −1,170,000 | $0.12 | $137,475 | 21,553,648 | I |
| NIGALAYE ASHOK G Chief Scientific Officer | 2013-11-19 | Sale | −21,000 | $0.12 | $2,457 | 21,547,348 | I |
| Open-market sales · 1,974,140 sh · avg $0.12 · $230,818 | |||||||
Loading xslF345X03/primary_doc.xml…